Results 31 to 40 of about 16,265,183 (153)
Coagulation Profile in Type 2 Diabetes Mellitus and its Association with Glycaemic Control and Long-term Complications: A Cross-sectional Study [PDF]
Introduction: Diabetes Mellitus (DM) causes numerous complications due to the formation of Advanced Glycation End-products (AGEs) in the presence of persistent hyperglycaemia.
Anindita Banerjee +3 more
doaj +1 more source
Abnormal activated partial thromboplastin time and malignancy
Malignancy often results in clotting abnormalities. The aetiology of haemostasis problems in cancer is complex, and is still not completely understood. We describe a case of a patient with malignant mesothelioma, who was found to have elevated activated
H Hambley, M Delicata
core +1 more source
Evaluation of Coagulation Profile and Transfusion Support in Pre-eclampsia Patients: A Cross-sectional Study [PDF]
Introduction: Pre-eclampsia (PE) is an obstetric disorder characterised by high morbidity and mortality rates, yet it lacks a definitive etiology.
Sivaranjani Vijayasundaram +3 more
doaj +1 more source
BackgroundCOVID-19 is a viral disease caused by a new strain of corona virus. Currently, prognosis and risk stratification of COVID-19 patients is done by the disease's clinical presentation.
Esayas Tekle +8 more
doaj +1 more source
Variation of activated partial thromboplastin time according to age and sex in a large population study: analytical and clinical ...
Borghi L. +5 more
core +1 more source
Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time [PDF]
The measurement of blood clotting time is important in a range of clinical applications such as assessing coagulation disorders and controlling the effect of various anticoagulant drug therapies.
Dudek, Magdalena +21 more
core +1 more source
A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen [PDF]
The wide availability of fibrinogen estimations based on the prothrombin time (PT-Fg) has caused concern about the variability and clinical utility of fibrinogen assays.
Lowe, G.D.O. +9 more
core +4 more sources
PARTIAL THROMBOPLASTIN TIME CHANGES IN ASTHMA
Study objective: To exam the effect of asthma on- coagulation pathway. Methods: Case control study with 73 asthmatic pagtients at different age. Results: We show that PIT in asthmatic patients is longer than in control group (P < 0.0001). We
A MIRALAEI, F AFSHINNIA
doaj
Hemostasis markers associated with tumors have been widely studied. However, the associations between the coagulation factors and papillary thyroid carcinoma (PTC) prognosis remain unclear.
Wang Yanhai +5 more
doaj +1 more source
Interference of spurious haemolysis on prothrombin time, activated partial thromboplastin time, and ...
LIPPI, Giuseppe, Ippolito L.
core +1 more source

